Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Reata Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 28 Jul 2023 | Biogen Acquires Reata Pharma for USD7.3 Billion | Acquisition |
Biogen Inc
|
Reata Pharmaceuticals Inc |
| 01 Jun 2023 | Reata Pharmaceuticals Inc Enters Phase I Clinical Trial Agreement with Celerion Inc for omaveloxolone (GDCT0490782) | Contract Service Agreement |
Reata Pharmaceuticals Inc
|
Celerion Inc
|
| 01 Jun 2023 | Reata Pharmaceuticals Inc Enters Phase I Clinical Trial Agreement with Altasciences Co Inc for omaveloxolone (GDCT0490782) | Contract Service Agreement |
Reata Pharmaceuticals Inc
|
Altasciences Co Inc
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer